Geron (LTS:0IV3) Total Stockholders Equity : $268.2 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Geron Total Stockholders Equity?

Geron's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $268.2 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Geron's Book Value per Share for the quarter that ended in Mar. 2025 was $0.42. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Geron's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.45.

Geron Total Stockholders Equity Historical Data

The historical data trend for Geron's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geron Total Stockholders Equity Chart

Geron Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

210.95

126.42

80.00

247.95

280.32

Geron Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															344.87	306.70	292.28	280.32	268.24

Geron (LTS:0IV3) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Geron's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(268.238	-	0)	/	636.918
	=	0.42

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Geron's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.981	+	120.797)	/	268.238
	=	0.45

Geron Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Geron's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Geron Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Geron Corp (LTS:0IV3) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

GERN:USA GON:Germany

Address

919 East Hillsdale Boulevard, Suite 250, Foster City, CA, USA, 94404

Website

https://www.geron.com

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Geron Headlines

No Headlines